Prof Peter Taylor (Oxford, UK) joins Dr David Liew to discuss results from the PERSIST study, a real-world, observational, prospective cohort study of CT-P13 for treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.

Read the paper here: https://doi.org/10.1093/rap/rkab026

This episode was originally published in December 2021.